ReviewSeminars in nuclear medicine2009
Genomic biomarkers for molecular imaging: predicting the future.
Review in Seminars in nuclear medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 29 citations in OpenAlex.
- High-grade left atrial intimal sarcoma mimicking myxoma: The diagnostic and therapeutic relevance of tumor topography.Journal of cardiology cases · 2026Article
- Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach.International journal of molecular sciences · 2021Review
- Theragnostic imaging using radiolabeled antibodies and tyrosine kinase inhibitors.TheScientificWorldJournal · 2015Review
- VPAC1 receptors for imaging breast cancer: a feasibility study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2013Article
- Nuclear imaging of the breast: translating achievements in instrumentation into clinical use.Medical physics · 2013Review
- Strategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatment.BioMed research international · 2013Review
- F-18 labeled vasoactive intestinal peptide analogue in the PET imaging of colon carcinoma in nude mice.BioMed research international · 2013Article
- Molecular imaging-challenges, opportunities and caveats.Journal of medical physics · 2011Article
- Current perspectives in medical image perception.Attention, perception & psychophysics · 2010Review
- Predictive and prognostic molecular markers for cancer medicine.Therapeutic advances in medical oncology · 2010Article
- Advanced modalities of molecular imaging in precision medicine for musculoskeletal malignancies.World journal of nuclear medicineReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Over the past few decades, great strides have been made in anatomical imaging of disease that has led to their diagnosis with minimal invasion. Despite these advances, diseases such as cancer continue to take one human life every minute in the United States. Complimentary approaches that pertain directly to the genesis of the disease might contribute to its early diagnosis and subsequent management. In cancer, an array of molecular abnormalities leading to the modulations in expression of key proteins important in the cellular signaling pathways and cell proliferation has been identified. These specific disease fingerprints, biomarkers, are overexpressed on malignant cell surfaces or within the cytoplasm, and they provide unique targets that are promising for improving cancer diagnosis and therapy. We and others have designed, synthesized, and evaluated some novel probes specific for those oncogenes and oncogene product biomarkers for PET and SPECT molecular imaging of certain types of cancers. This article briefly describes this approach and gives specific examples that depict the ability of molecular imaging to detect occult lesions not detectable by current scintigraphic approaches. The article also outlines a few examples predicting other possible applications of targeting such specific probes not yet used.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.